Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fairshter, R. D.
Right arrow Articles by Wilson, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairshter, R. D.
Right arrow Articles by Wilson, A. F.

Chest, Vol 79, 50-57, Copyright © 1981 by American College of Chest Physicians

ARTICLES

Site and duration of bronchodilation in asthmatic patients after oral administration of terbutaline

RD Fairshter, HS Novey and AF Wilson

We compared pulmonary function in 15 asthmatic subjects before and after ingestion of 5 mg terbutaline and placebo. Measurements of maximal expiratory flow (VEmax), density-dependence of VEmax (delta VEmax50), volume of isoflow (Viso V), residual volume (RV), and closing capacity (CC) were performed before and 15, 135, 255, and 375 minutes after both treatments. After placebo VEmax improved mildly (P < 0.05) but no significant changes occurred in delta VEmax50, VisoV, RV, or CC. After terbutaline, VEmax increased significantly and VisoV, RV, and CC decreased significantly at all time periods studied. In addition delta VEmax50 increased compared to baseline at 15 and 135 minutes (P < 0.05) and compared to placebo at 135 and 255 minutes (P < 0.05). In our study, orally administered terbutaline apparently caused predominant peripheral airways bronchodilatation in the first few hours after ingestion. Afterwards, the predominant small airways effect appeared to wane, and large and small airways were dilated proportionately equally 375 minutes after oral administration of terbutaline.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American College of Chest Physicians.